Biomarker Testing

BIOLOGICAL2 trials

Sponsors

Unity Health Toronto, M.D. Anderson Cancer Center

Conditions

Colorectal CancerStage I-IV Breast Cancer (Neo-adjuvant, Adjuvant, Locally Advanced and Metastatic)

Unknown Phase

Assessment of Cardiotoxicity by Cardiac Magnetic Resonance (CMR) in Breast Cancer Patients Receiving Trastuzumab

Unity Health TorontoStage I-IV Breast Cancer (Neo-adjuvant, Adjuvant, Locally Advanced and Metastatic)

Start: 2009-11-30End: 2019-12-31Target: 50Updated: 2017-07-12

Colorectal Cancer Umbrella Protocol - Assessment of Targeted Therapies Against Colorectal Cancer (ATTACC Program) Screening Protocol

CompletedNCT01196130

M.D. Anderson Cancer CenterColorectal Cancer

Start: 2010-08-31End: 2022-12-09Updated: 2022-12-13

Related Papers

NeoRAS: Incidence of RAS reversion from RAS mutated to RAS wild type.

Journal of Clinical Oncology2020-02-0120 citations

Early diastolic strain rate measurements by cardiac MRI in breast cancer patients treated with trastuzumab: a longitudinal study.

2018-11-0223 citations

Longitudinal assessment of right ventricular structure and function by cardiovascular magnetic resonance in breast cancer patients treated with trastuzumab: a prospective observational study.

2017-04-1038 citations

Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials.

2016-02-1821 citations